Itraconazole 65mg / 130mg (Supra-Bioavailable) is an advanced antifungal formulation designed for improved absorption and enhanced therapeutic effectiveness. The supra-bioavailable technology ensures higher and more consistent blood levels compared to conventional itraconazole capsules, leading to better clinical outcomes in fungal infections. Itraconazole is a broad-spectrum triazole antifungal agent that works by inhibiting fungal cell membrane synthesis, effectively treating a wide range of superficial and systemic fungal infections. It is commonly prescribed for dermatophytosis, onychomycosis, candidiasis, and other resistant fungal infections. The 65mg and 130mg strengths allow flexible dosing based on severity and type of infection, ensuring optimized therapy with improved patient compliance.
